HLA-A

Overview

Mutations in the HLA-A gene have been associated with a loss of cell surface expression of HLA class I molecules, which are essential for presenting tumor antigens to cytotoxic T cells. This is a common mechanism of immune escape in DLBCL. Different approaches for mapping sequencing data can complicate the detection of mutations in this and other HLA genes. Likely owing to this, the rate of mutations is highly variable across studies. Deletions of this gene are more commonly reported than HLA-A mutations.1

Relevance tier by entity

Entity Tier Description
BL 2 relevance in BL not firmly established
DLBCL 1 high-confidence DLBCL gene

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
DLBCL GAMBL genomes 7.46
DLBCL Schmitz cohort 11.06
DLBCL Reddy cohort 0.20
DLBCL Chapuy cohort 8.97
BL GAMBL genomes+capture 1.39
BL Thomas cohort 1.30
BL Panea cohort NA

Mutation pattern and selective pressure estimates

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
BL No No 4.995 22.371
DLBCL No Yes 14.841 190.534
FL No No 0.000 0.000

## HLA-A Hotspots

Chromosome Coordinate (hg19) ref>alt HGVSp
chr6 29910596 T>A F46I
chr6 29910609 G>A G50D

View coding variants in ProteinPaint hg19 or hg38

image

View all variants in GenomePaint hg19 or hg38

image

References

  1. Riemersma, S., Jordanova, E., Schop, R., Philippo, K., Looijenga, L., Schuuring, E., & Kluin, P. (2000). Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.. Blood, 96 10, 3569-77 . https://doi.org/10.1182/BLOOD.V96.10.3569.